Scribd Logo
Upload

Welcome to Scribd!

  • 149 views

    Continuing Medical Education: CME Multiple Choice Questions

    Uploaded by

    HardiTariqHamma
    This document contains a 6 question multiple choice quiz on testosterone therapy and hypogonadism. 1. The questions cover topics like the effects of testosterone replacement therapy, factors that control the PDE5 gene, testosterone alkylation, and the risks and benefits of testosterone therapy. 2. Answers are requested for questions about screening tools for hypogonadism, the association between testosterone therapy and prostate cancer risk, and the uses and side effects of testosterone formulations. 3. At the end, participants are asked to evaluate the learning activity and indicate how they will apply the new knowledge in practice.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Continuing Medical Education: CME Multiple Choice Questions

    Uploaded by

    HardiTariqHamma
    149 views1 page
    This document contains a 6 question multiple choice quiz on testosterone therapy and hypogonadism. 1. The questions cover topics like the effects of testosterone replacement therapy, factors that control the PDE5 gene, testosterone alkylation, and the risks and benefits of testosterone therapy. 2. Answers are requested for questions about screening tools for hypogonadism, the association between testosterone therapy and prostate cancer risk, and the uses and side effects of testosterone formulations. 3. At the end, participants are asked to evaluate the learning activity and indicate how they will apply the new knowledge in practice.

    Original Title

    cme-multiple-choice-questions-2011

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document contains a 6 question multiple choice quiz on testosterone therapy and hypogonadism. 1. The questions cover topics like the effects of testosterone replacement therapy, factors that control the PDE5 gene, testosterone alkylation, and the risks and benefits of testosterone therapy. 2. Answers are requested for questions about screening tools for hypogonadism, the association between testosterone therapy and prostate cancer risk, and the uses and side effects of testosterone formulations. 3. At the end, participants are asked to evaluate the learning activity and indicate how they will apply the new knowledge in practice.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    149 views1 page

    Continuing Medical Education: CME Multiple Choice Questions

    Uploaded by

    HardiTariqHamma
    This document contains a 6 question multiple choice quiz on testosterone therapy and hypogonadism. 1. The questions cover topics like the effects of testosterone replacement therapy, factors that control the PDE5 gene, testosterone alkylation, and the risks and benefits of testosterone therapy. 2. Answers are requested for questions about screening tools for hypogonadism, the association between testosterone therapy and prostate cancer risk, and the uses and side effects of testosterone formulations. 3. At the end, participants are asked to evaluate the learning activity and indicate how they will apply the new knowledge in practice.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    Continuing Medical Education

    CME Multiple Choice Questions jsm_2206 655

    1. Testosterone therapy in hypogonadal patients 4. Testosterone replacement therapy


    with erectile dysfunction a) Improves body composition.
    a) Improves the response to PDE5 inhibitors. b) Reduces the risk of fracture in osteoporotic
    b) Cannot be used in association with PDE5 men.
    inhibitors. c) Increases men’s life expectancies.
    c) Is not useful. d) Reduces muscular strength.
    d) Is useful only in diabetic patients.
    5. Self-reported questionnaires for the screening
    of hypogonadism have demonstrated
    2. The PDE5 gene is under the control of
    a) Good sensitivity but low specificity.
    a) Estrogens.
    b) Good specificity and sensitivity.
    b) Prolactin.
    c) Poor specificity and sensitivity.
    c) DHT.
    d) Good specificity but low sensitivity.
    d) Testosterone.
    6. Testosterone replacement therapy is associated
    3. Testosterone alkylation in 17-a position with
    a) Prevents rapid breakdown in the liver a) No evidence of increasing risk for prostate
    causing hepatoxicity. cancer.
    b) Prevents rapid breakdown in the liver b) Increased risk for prostate cancer.
    without any side effects. c) Reduced risk for prostate cancer.
    c) Allows parental administration. d) Increased risk for benign prostatic
    d) Allows transdermal administration. hyperplasia.

    Overall evaluation of the activity What degree of confidence do you have that you will apply your new
    a. Excellent learning in your practice?
    b. Very good 100%
    c. Good 75%
    d. Fair 50%
    e. Poor 25%
    0%
    Was this activity responsive to your needs? What one change will you make in your practice based on this new learning?
    Yes
    No List any topics you would find interesting and professionally relevant for
    future CME activities:
    Was this activity relevant to your practice? This activity is designed for a maximum of 1 category 1 credit. You should
    Yes only claim the number of credits you have earned based on the amount of
    No time needed to complete this activity. How many credits are you claiming
    for this activity?
    Did this activity increase your knowledge and/or skills in delivering patient a. 1
    care? b. 0.75
    Yes c. 0.5
    No d. 0.25

    Please indicate your current profession: Address 2:


    䊐 Physician 䊐 Nurse
    䊐 Physician Assistant 䊐 Other Healthcare Professional City:
    䊐 Nurse Practitioner 䊐 Other
    State:
    Name: Postal Code:
    Institution: Country:

    Address 1: Email Address:

    An online version of this activity is now available. If you wish to receive credit for this activity, please refer to the website: www.wileyblackwellcme.com.
    Alternatively, this page can be sent by fax to Blackwell Futura Media Services, at (781)-338-8325. If you do not receive your certificate within 30 days of
    submission, please contact David Kempe, Editorial Program Coordinator, at dkempe@wiley.com.

    J Sex Med 2011;8:655 655

    You might also like